ArticleJournal of clinical laboratory analysis2026
RETRACTION: A Long Non-Coding RNA OLBC15 Promotes Triple-Negative Breast Cancer Progression Via Enhancing ZNF326 Degradation.
Article in Journal of clinical laboratory analysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Retraction of
Authors and funding
0 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
retractionC. Deng, B. Zhang, Y. Zhang, X. Xu, D. Xiong, X. Chen, and J. Wu, "A Long Non-Coding RNA OLBC15 Promotes Triple-Negative Breast Cancer Progression Via Enhancing ZNF326 Degradation," Journal of Clinical Laboratory Analysis 34, no. 8 (2020): e23304, https://doi.org/10.1002/jcla.23304. The above article, published online on 24 April 2020, in Wiley Online Library (http://onlinelibrary.wiley.com/), has been retracted by agreement between the authors; the journal Editor-in-Chief, Rong Fu; and Wiley Periodicals, LLC. The corresponding author Jiaojiao Wu contacted the journal to request that the article be retracted for the following reasons: 1. An inability to reproduce key experimental results; 2. Technical errors in the experimental protocols that may have compromised the reliability and reproducibility of the data (inconsistencies in RNA pulldown assay conditions, potential cross-contamination in cell line experiments, and insufficient validation of antibody specificity for ZNF326 detection); and 3. Discrepancies in the original data, calling into question the western blot images in Figures 4B, 5A, and 5B; the quantification data for migration assays; and IHC scoring consistency in clinical samples. Following an investigation, images in Figures 4 and 5 were found to be duplicated from earlier publications: Figure 4D being from Figure 3A in Koo et al. 2017 (https://doi.org/10.1158/1535-7163.MCT-17-0077), Figure 5B being from Figure 5B in Shen et al. 2019 (https://doi.org/10.1002/jcla.23122), and Figure 5E being from Figure 2G in Li et al. 2018 (https://doi.org/10.2147/CMAR.S183355). Due to the scope of these errors, the editor has lost confidence in the results reported, and therefore the article must be retracted.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.